Web Results

ltd.aruplab.com/Tests/Pub/2001601

RNA polymerase III IgG antibody occur in about 11-23 percent of SSc patients, and typically in the absence of anti-centromere and anti-Scl-70 antibodies. A negative result indicates no detectable IgG antibodies to the dominant antigen of RNA polymerase III and does not rule out the possibility of SSc.

testdirectory.questdiagnostics.com/test/test-detail/19899/rna-polymerase-iii...

Please provide SERVICE AREA INFORMATION to confirm Test Code for the lab that services your account or to find available tests you can order. Clinical Significance. RNA Polymerase III Antibody - To aid in the diagnosis of systemic sclerosis. Test Resources. Clinical Focus Autoimmune Rheumatic and Related Diseases . Clinical Focus

www.wieslab.com/diagnostic-services/index.php?headId=72&pageId=116&subId=116&...

Antibodies against RNA polymerase are markers for systemic sclerosis and can be detected in approximately 20% of patients. Anti-RNA Polymerase I and above all anti-RNA polymerase III have high association with diffuse systemic sclerosis and is associated with increased risk of internal organs involvement.

www.ncbi.nlm.nih.gov/pmc/articles/PMC1905338

There are three classes of RNA polymerase enzyme (RNAPs I, II and III). In systemic sclerosis (SSc), three main groups of anti-RNAP sera have been characterized by radioimmunoprecipitation techniques: anti-RNAP I/III sera, anti-RNAP I/II/III sera, and a group precipitating both RNAP II and topoisomerase I (topo I).

www.inspire.com/groups/scleroderma-foundation/discussion/anti-rna-polymerase-3...

The doctor may even inappropriately treat this patient with steroids, actually bringing on an attack of renal crisis. Meanwhile, the patient, also clueless about his antibody status is likely checking his blood pressure once a week or less, instead of twice daily, which I've read is what is recommended for anti-rna polymerase 3 patients.

www.aruplab.com/guides/ug/tests/2001601.jsp

RNA polymerase III IgG antibody occur in about 11-23 percent of SSc patients, and typically in the absence of anti-centromere and anti-Scl-70 antibodies. A negative result indicates no detectable IgG antibodies to the dominant antigen of RNA polymerase III and does not rule out the possibility of SSc.

www.sclero.org/scleroderma/diagnosis/tests/antibodies-ssc.html

Cancers associated with systemic sclerosis (SSc) involving anti-RNA polymerase III antibodies. Anti-RNA polymerase III antibodies are useful for SSc diagnosis in patients without anti-centromere or anti-Scl70 antibodies and their presence must lead physicians to screen for associated cancer, even in the absence of clinical signs.

www.labcorp.com/tests/161455/anti-jo-1

Anti-Jo-1 antibodies are present in approximately 20% to 30% of patients with adult-onset polymyositis syndromes. They are present in >65% of patients with both myositis and interstitial lung disease. In such patients, the presence of anti-Jo-1 antibodies may be predictive of a response to steroid treatment.

www.medicalnewstoday.com/articles/320736

The HCV RNA PCR test is a blood test. A lab technician looks for the genetic material of the HCV virus, or its ribonucleic acid (RNA). They use a process called a polymerase chain reaction (PCR).

en.wikipedia.org/wiki/Anti-nuclear_antibody

Anti-double stranded DNA (anti-dsDNA) antibodies are highly associated with SLE. They are a very specific marker for the disease, with some studies quoting nearly 100%. Data on sensitivity ranges from 25–85%. Anti-dsDNA antibody levels, known as titres, correlate with disease activity in SLE; high levels indicate more active lupus.